DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $27,594,667 | +38.7% | 2,074,787 | -6.5% | 32.85% | +6.7% |
Q3 2023 | $19,891,505 | -20.4% | 2,220,034 | 0.0% | 30.79% | -5.6% |
Q2 2023 | $24,975,383 | -2.3% | 2,220,034 | 0.0% | 32.61% | -6.8% |
Q1 2023 | $25,574,792 | -0.6% | 2,220,034 | 0.0% | 34.99% | +1.2% |
Q4 2022 | $25,730,194 | -8.7% | 2,220,034 | 0.0% | 34.58% | +36.6% |
Q3 2022 | $28,194,000 | +38.6% | 2,220,034 | -25.0% | 25.30% | +47.3% |
Q2 2022 | $20,335,000 | -28.7% | 2,960,046 | 0.0% | 17.18% | +3.5% |
Q1 2022 | $28,535,000 | -18.9% | 2,960,046 | 0.0% | 16.60% | +26.1% |
Q4 2021 | $35,195,000 | -26.8% | 2,960,046 | 0.0% | 13.16% | -4.4% |
Q3 2021 | $48,071,000 | -22.8% | 2,960,046 | 0.0% | 13.77% | -11.8% |
Q2 2021 | $62,280,000 | +35.5% | 2,960,046 | 0.0% | 15.62% | +34.5% |
Q1 2021 | $45,970,000 | -26.0% | 2,960,046 | 0.0% | 11.61% | -9.0% |
Q4 2020 | $62,161,000 | +4.0% | 2,960,046 | 0.0% | 12.76% | -65.9% |
Q3 2020 | $59,764,000 | – | 2,960,046 | – | 37.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |